In Vitro Enzyme Assay of CYP21A2 Mutation (R483Q) by A Novel Method Using Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS/MS).

导出 LinkOut

翻译打印收藏纠错

作者： Makoto,Ono ^[1] ; Kenichi,Kashimada ^[1] ; Kentaro,Miyai ^[1] ; Toshikazu,Onishi ^[1] ; Masatoshi,Takagi ^[1] ; Seijiro,Honma ^[2] ; Shuki,Mizutani ^[1]

作者单位： Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan. ^[1] Teikoku Hormone Medical Co. Ltd., Kawasaki, Japan. ^[2]

关键词 21-hydroxylase deficiency (21-OHD)CYP21A2 LC-ESI-MS/MS enzyme assay

DOI 10.1297/cpe.17.49

PMID 24790362

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览8

Clinical pediatric endocrinology

2008年17卷2期

49-56页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

In Vitro Enzyme Assay of CYP21A2 Mutation (R483Q) by A Novel Method Using Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS/MS).

Clinical pediatric endocrinology

相似文献

Clinical pediatric endocrinology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

In Vitro Enzyme Assay of CYP21A2 Mutation (R483Q) by A Novel Method Using Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry (LC-ESI-MS/MS).

Clinical pediatric endocrinology

相似文献

Clinical pediatric endocrinology

相关期刊

检索历史清除